Company Filing History:
Years Active: 2011
Title: Innovations by Rebecca Caffrey in Chagas Disease Research.
Introduction
Rebecca Caffrey is an accomplished inventor based in Mountain View, CA (US). She has made significant contributions to the field of medical research, particularly in the diagnosis of Chagas disease. Her innovative work focuses on developing biomarkers that can aid in the detection and classification of this disease.
Latest Patents
Rebecca Caffrey holds 1 patent for her invention titled "Serum biomarkers for Chagas disease." This invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Chagas disease status in a patient. The biomarkers developed by Caffrey are particularly effective in classifying a subject sample as either infected with Chagas disease or non-infected. These biomarkers can be detected using SELDI mass spectrometry, showcasing a significant advancement in diagnostic methods.
Career Highlights
Rebecca Caffrey is affiliated with McGill University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on public health, especially in regions where Chagas disease is prevalent. Caffrey's dedication to her field is evident in her innovative approach to solving complex medical challenges.
Collaborations
Throughout her career, Rebecca has collaborated with notable colleagues, including Momar Ndao and Brian Ward. These partnerships have enhanced her research capabilities and contributed to the advancement of her projects.
Conclusion
Rebecca Caffrey's contributions to the field of Chagas disease research exemplify the importance of innovation in medical diagnostics. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes.